Regulatory Press Releases

Stille AB reports that Torbjörn Sköld, incoming CEO starting March 20th, 2023, purchased 8,770 shares in Stille on January 31st, 2023. The shares were purchased at 114 SEK per share, with a total value of 997,780 SEK. Torshälla, February 2nd, 2023. For more information, please contact: Niklas Carlén Interim CEO and President +46 (0)73 087 49 70 | niklas.carlen@stille.se Stille...

Torbjörn Sköld will begin his tenure as new Stille’s new CEO on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Stille’s board of directors have decided to appoint Niklas Carlén as Interim CEO up until Torbjörn will commence his employment. Niklas has been the company’s CFO since June...

Torbjörn will begin his tenure on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Torbjörn comes most recently from De Puy Synthes EMEA, a Johnson & Johnson company, where he has been Vice President. Lars Kvarnhem, chairman of the board comments today’s announcement: “First, I would like to thank Hanna...

Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items. Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4). Profitability was affected by an unfavorable product and geographic market mix. Surgical Table-revenues grew by 30 percent to...

Revenues increased by 56 percent to 63.3 MSEK (40.6) and the organic growth amounted to 14 percent with revenues of 46.1 MSEK. Operating profit increased by 72 percent 8.9 MSEK (5.2). Compared to the same quarter last year, business unit Surgical Instruments doubled its revenue driven by the acquired volume of S&T. For the same period, business unit Surgical Tables increased sales by 25 percent...